Stocks and Investing Stocks and Investing
Mon, May 8, 2023

Andrew Berens Maintained (VIRX) at Buy and Held Target at $11 on, May 8th, 2023


Published on 2024-10-28 03:28:59 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Securities, Maintained "Viracta Therapeutics, Inc." (VIRX) at Buy and Held Target at $11 on, May 8th, 2023.

Andrew has made no other calls on VIRX in the last 4 months.



There are 3 other peers that have a rating on VIRX. Out of the 3 peers that are also analyzing VIRX, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $16 on, Monday, March 27th, 2023
  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Tuesday, March 14th, 2023
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $8 on, Tuesday, March 14th, 2023
Contributing Sources